0.016395 0.000000 0.004940 0.000000 0.017109 0.000000 0.000000 0.000000 0.014203 0.00000 0.00000 0.00000 Glithero, A. Tormo, J. Doering, K. Kojima, M. Jones, E.Y. Elliott, T. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 2 90.00 106.77 90.00 60.996 58.450 73.534 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C3 H8 O3 92.094 GLYCEROL GLYCERIN; PROPANE-1,2,3-TRIOL non-polymer C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking H2 O 18.015 WATER non-polymer C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking N 1 N N N 2 S C N 3 N C N 4 N O N 5 N C N 6 N O N 7 N H N 8 N H N 9 N H N 10 N H N 11 N H N 12 N H N 13 N H N 14 N N N 15 S C N 16 N C N 17 N O N 18 N C N 19 N C N 20 N C N 21 N N N 22 N C N 23 N N N 24 N N N 25 N O N 26 N H N 27 N H N 28 N H N 29 N H N 30 N H N 31 N H N 32 N H N 33 N H N 34 N H N 35 N H N 36 N H N 37 N H N 38 N H N 39 N H N 40 N H N 41 N N N 42 S C N 43 N C N 44 N O N 45 N C N 46 N C N 47 N O N 48 N N N 49 N O N 50 N H N 51 N H N 52 N H N 53 N H N 54 N H N 55 N H N 56 N H N 57 N H N 58 N N N 59 S C N 60 N C N 61 N O N 62 N C N 63 N C N 64 N O N 65 N O N 66 N O N 67 N H N 68 N H N 69 N H N 70 N H N 71 N H N 72 N H N 73 N H N 74 N N N 75 R C N 76 N C N 77 N O N 78 N C N 79 N S N 80 N O N 81 N H N 82 N H N 83 N H N 84 N H N 85 N H N 86 N H N 87 N H N 88 N N N 89 S C N 90 N C N 91 N O N 92 N C N 93 N C N 94 N C N 95 N O N 96 N N N 97 N O N 98 N H N 99 N H N 100 N H N 101 N H N 102 N H N 103 N H N 104 N H N 105 N H N 106 N H N 107 N H N 108 N N N 109 S C N 110 N C N 111 N O N 112 N C N 113 N C N 114 N C N 115 N O N 116 N O N 117 N O N 118 N H N 119 N H N 120 N H N 121 N H N 122 N H N 123 N H N 124 N H N 125 N H N 126 N H N 127 N N N 128 N C N 129 N C N 130 N O N 131 N O N 132 N H N 133 N H N 134 N H N 135 N H N 136 N H N 137 N C N 138 N O N 139 N C N 140 N O N 141 N C N 142 N O N 143 N H N 144 N H N 145 N H N 146 N H N 147 N H N 148 N H N 149 N H N 150 N H N 151 N N N 152 S C N 153 N C N 154 N O N 155 N C Y 156 N C Y 157 N N Y 158 N C Y 159 N C Y 160 N N N 161 N O N 162 N H N 163 N H N 164 N H N 165 N H N 166 N H N 167 N H N 168 N H N 169 N H N 170 N H N 171 N H N 172 N O N 173 N H N 174 N H N 175 N N N 176 S C N 177 N C N 178 N O N 179 S C N 180 N C N 181 N C N 182 N C N 183 N O N 184 N H N 185 N H N 186 N H N 187 N H N 188 N H N 189 N H N 190 N H N 191 N H N 192 N H N 193 N H N 194 N H N 195 N H N 196 N H N 197 N N N 198 S C N 199 N C N 200 N O N 201 N C N 202 N C N 203 N C N 204 N C N 205 N O N 206 N H N 207 N H N 208 N H N 209 N H N 210 N H N 211 N H N 212 N H N 213 N H N 214 N H N 215 N H N 216 N H N 217 N H N 218 N H N 219 N N N 220 S C N 221 N C N 222 N O N 223 N C N 224 N C N 225 N C N 226 N C N 227 N N N 228 N O N 229 N H N 230 N H N 231 N H N 232 N H N 233 N H N 234 N H N 235 N H N 236 N H N 237 N H N 238 N H N 239 N H N 240 N H N 241 N H N 242 N H N 243 N H N 244 N N N 245 S C N 246 N C N 247 N O N 248 N C N 249 N C N 250 N S N 251 N C N 252 N O N 253 N H N 254 N H N 255 N H N 256 N H N 257 N H N 258 N H N 259 N H N 260 N H N 261 N H N 262 N H N 263 N H N 264 N N N 265 S C N 266 N C N 267 N O N 268 N C Y 269 N C Y 270 N C Y 271 N C Y 272 N C Y 273 N C Y 274 N C N 275 N O N 276 N H N 277 N H N 278 N H N 279 N H N 280 N H N 281 N H N 282 N H N 283 N H N 284 N H N 285 N H N 286 N H N 287 N N N 288 S C N 289 N C N 290 N O N 291 N C N 292 N C N 293 N C N 294 N O N 295 N H N 296 N H N 297 N H N 298 N H N 299 N H N 300 N H N 301 N H N 302 N H N 303 N H N 304 N N N 305 S C N 306 N C N 307 N O N 308 N C N 309 N O N 310 N O N 311 N H N 312 N H N 313 N H N 314 N H N 315 N H N 316 N H N 317 N H N 318 N N N 319 S C N 320 N C N 321 N O N 322 R C N 323 N O N 324 N C N 325 N O N 326 N H N 327 N H N 328 N H N 329 N H N 330 N H N 331 N H N 332 N H N 333 N H N 334 N H N 335 N N N 336 S C N 337 N C N 338 N O N 339 N C Y 340 N C Y 341 N C Y 342 N C Y 343 N N Y 344 N C Y 345 N C Y 346 N C Y 347 N C Y 348 N C N 349 N O N 350 N H N 351 N H N 352 N H N 353 N H N 354 N H N 355 N H N 356 N H N 357 N H N 358 N H N 359 N H N 360 N H N 361 N H N 362 N N N 363 S C N 364 N C N 365 N O N 366 N C Y 367 N C Y 368 N C Y 369 N C Y 370 N C Y 371 N C Y 372 N C N 373 N O N 374 N O N 375 N H N 376 N H N 377 N H N 378 N H N 379 N H N 380 N H N 381 N H N 382 N H N 383 N H N 384 N H N 385 N H N 386 N N N 387 S C N 388 N C N 389 N O N 390 N C N 391 N C N 392 N C N 393 N O N 394 N H N 395 N H N 396 N H N 397 N H N 398 N H N 399 N H N 400 N H N 401 N H N 402 N H N 403 N H N 404 N H N 1 N sing N 2 N sing N 3 N sing N 4 N sing N 5 N sing N 6 N sing N 7 N doub N 8 N sing N 9 N sing N 10 N sing N 11 N sing N 12 N sing N 13 N sing N 14 N sing N 15 N sing N 16 N sing N 17 N sing N 18 N sing N 19 N doub N 20 N sing N 21 N sing N 22 N sing N 23 N sing N 24 N sing N 25 N sing N 26 N sing N 27 N sing N 28 N sing N 29 N sing N 30 N sing N 31 N sing N 32 N sing N 33 N doub N 34 N sing N 35 N sing N 36 N sing N 37 N sing N 38 N sing N 39 N sing N 40 N sing N 41 N sing N 42 N sing N 43 N sing N 44 N sing N 45 N doub N 46 N sing N 47 N sing N 48 N sing N 49 N sing N 50 N doub N 51 N sing N 52 N sing N 53 N sing N 54 N sing N 55 N sing N 56 N sing N 57 N sing N 58 N sing N 59 N sing N 60 N sing N 61 N doub N 62 N sing N 63 N sing N 64 N sing N 65 N sing N 66 N doub N 67 N sing N 68 N sing N 69 N sing N 70 N sing N 71 N sing N 72 N sing N 73 N sing N 74 N sing N 75 N sing N 76 N doub N 77 N sing N 78 N sing N 79 N sing N 80 N sing N 81 N sing N 82 N sing N 83 N sing N 84 N sing N 85 N sing N 86 N sing N 87 N sing N 88 N sing N 89 N doub N 90 N sing N 91 N sing N 92 N sing N 93 N sing N 94 N sing N 95 N sing N 96 N sing N 97 N doub N 98 N sing N 99 N sing N 100 N sing N 101 N sing N 102 N sing N 103 N sing N 104 N sing N 105 N sing N 106 N sing N 107 N sing N 108 N doub N 109 N sing N 110 N sing N 111 N sing N 112 N sing N 113 N sing N 114 N sing N 115 N sing N 116 N doub N 117 N sing N 118 N sing N 119 N sing N 120 N sing N 121 N sing N 122 N sing N 123 N sing N 124 N sing N 125 N sing N 126 N doub N 127 N sing N 128 N sing N 129 N sing N 130 N sing N 131 N sing N 132 N sing N 133 N sing N 134 N sing N 135 N sing N 136 N sing N 137 N sing N 138 N sing N 139 N sing N 140 N sing N 141 N sing N 142 N sing N 143 N sing N 144 N sing N 145 N sing N 146 N sing N 147 N sing N 148 N doub N 149 N sing N 150 N sing N 151 N sing N 152 N sing Y 153 N sing Y 154 N doub Y 155 N doub N 156 N sing Y 157 N sing N 158 N sing Y 159 N sing N 160 N sing N 161 N sing N 162 N sing N 163 N sing N 164 N sing N 165 N sing N 166 N sing N 167 N sing N 168 N sing N 169 N sing N 170 N sing N 171 N doub N 172 N sing N 173 N sing N 174 N sing N 175 N sing N 176 N sing N 177 N sing N 178 N sing N 179 N sing N 180 N sing N 181 N sing N 182 N sing N 183 N sing N 184 N sing N 185 N sing N 186 N sing N 187 N sing N 188 N sing N 189 N sing N 190 N sing N 191 N sing N 192 N doub N 193 N sing N 194 N sing N 195 N sing N 196 N sing N 197 N sing N 198 N sing N 199 N sing N 200 N sing N 201 N sing N 202 N sing N 203 N sing N 204 N sing N 205 N sing N 206 N sing N 207 N sing N 208 N sing N 209 N sing N 210 N sing N 211 N sing N 212 N sing N 213 N doub N 214 N sing N 215 N sing N 216 N sing N 217 N sing N 218 N sing N 219 N sing N 220 N sing N 221 N sing N 222 N sing N 223 N sing N 224 N sing N 225 N sing N 226 N sing N 227 N sing N 228 N sing N 229 N sing N 230 N sing N 231 N sing N 232 N sing N 233 N sing N 234 N sing N 235 N sing N 236 N sing N 237 N doub N 238 N sing N 239 N sing N 240 N sing N 241 N sing N 242 N sing N 243 N sing N 244 N sing N 245 N sing N 246 N sing N 247 N sing N 248 N sing N 249 N sing N 250 N sing N 251 N sing N 252 N sing N 253 N sing N 254 N sing N 255 N sing N 256 N doub N 257 N sing N 258 N sing N 259 N sing N 260 N sing Y 261 N doub Y 262 N sing Y 263 N sing N 264 N sing Y 265 N doub N 266 N sing Y 267 N doub N 268 N sing Y 269 N sing N 270 N sing N 271 N sing N 272 N sing N 273 N sing N 274 N sing N 275 N sing N 276 N sing N 277 N sing N 278 N sing N 279 N doub N 280 N sing N 281 N sing N 282 N sing N 283 N sing N 284 N sing N 285 N sing N 286 N sing N 287 N sing N 288 N sing N 289 N sing N 290 N sing N 291 N sing N 292 N sing N 293 N sing N 294 N sing N 295 N sing N 296 N doub N 297 N sing N 298 N sing N 299 N sing N 300 N sing N 301 N sing N 302 N sing N 303 N sing N 304 N sing N 305 N sing N 306 N sing N 307 N sing N 308 N sing N 309 N doub N 310 N sing N 311 N sing N 312 N sing N 313 N sing N 314 N sing N 315 N sing N 316 N sing N 317 N sing N 318 N sing N 319 N sing N 320 N sing N 321 N sing N 322 N sing N 323 N sing N 324 N sing N 325 N doub N 326 N sing N 327 N sing N 328 N sing N 329 N sing Y 330 N doub Y 331 N sing Y 332 N sing N 333 N sing Y 334 N doub Y 335 N sing Y 336 N sing N 337 N sing Y 338 N sing Y 339 N doub N 340 N sing Y 341 N doub N 342 N sing Y 343 N sing N 344 N sing N 345 N sing N 346 N sing N 347 N sing N 348 N sing N 349 N sing N 350 N sing N 351 N sing N 352 N sing N 353 N doub N 354 N sing N 355 N sing N 356 N sing N 357 N sing Y 358 N doub Y 359 N sing Y 360 N sing N 361 N sing Y 362 N doub N 363 N sing Y 364 N doub N 365 N sing Y 366 N sing N 367 N sing N 368 N sing N 369 N sing N 370 N sing N 371 N sing N 372 N sing N 373 N sing N 374 N sing N 375 N sing N 376 N sing N 377 N doub N 378 N sing N 379 N sing N 380 N sing N 381 N sing N 382 N sing N 383 N sing N 384 N sing N 385 N sing N 386 N sing N 387 N sing N 388 N sing US J. Biol. Chem. JBCHA3 0071 0021-9258 281 12699 12704 10.1074/jbc.M511683200 16478731 The crystal structure of H-2D(b) complexed with a partial peptide epitope suggests a major histocompatibility complex class I assembly intermediate. 2006 10.2210/pdb2cii/pdb pdb_00002cii 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 100.0 1 CCD 1997-05-15 MARRESEARCH SINGLE WAVELENGTH M x-ray 1 1.488 1.0 PX7.2 SRS 1.488 SYNCHROTRON SRS BEAMLINE PX7.2 31933.535 H-2 CLASS I HISTOCOMPATIBILITY ANTIGEN D-B ALPHA CHAIN RESIDUES 25-299 1 man polymer 11748.160 BETA-2-MICROGLOBULIN 1 man polymer 949.060 NUCLEOPROTEIN RESIDUES 324-332 1 syn polymer 92.094 GLYCEROL 2 syn non-polymer 18.015 water 101 nat water H-2DB BETA2-M N PROTEIN, NUCLEOCAPSID PROTEIN, NP PROTEIN no no GPHSMRYFETAVSRPGLEEPRYISVGYVDNKEFVRFDSDAENPRYEPRAPWMEQEGPEYWERETQKAKGQEQWFRVSLRN LLGYYNQSAGGSHTLQQMSGCDLGSDWRLLRGYLQFAYEGRDYIALNEDLKTWTAADMAAQITRRKWEQSGAAEHYKAYL EGECVEWLHRYLKNGNATLLRTDSPKAHVTHHPRSKGEVTLRCWALGFYPADITLTWALNGEELTQDMELVETRPAGDGT FQKWASVVVPLGKEQNYTCRVYHEGLPEPLTLRWE GPHSMRYFETAVSRPGLEEPRYISVGYVDNKEFVRFDSDAENPRYEPRAPWMEQEGPEYWERETQKAKGQEQWFRVSLRN LLGYYNQSAGGSHTLQQMSGCDLGSDWRLLRGYLQFAYEGRDYIALNEDLKTWTAADMAAQITRRKWEQSGAAEHYKAYL EGECVEWLHRYLKNGNATLLRTDSPKAHVTHHPRSKGEVTLRCWALGFYPADITLTWALNGEELTQDMELVETRPAGDGT FQKWASVVVPLGKEQNYTCRVYHEGLPEPLTLRWE A polypeptide(L) no no IQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKDWSFYLLYYTEFTPTEKDEYAC RVNHVTLSQPKIVKWDRDM IQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKDWSFYLLYYTEFTPTEKDEYAC RVNHVTLSQPKIVKWDRDM B polypeptide(L) no no FAPGNYPAL FAPGNYPAL C polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n MOUSE sample 10090 MUS MUSCULUS 469008 ESCHERICHIA COLI BL21(DE3) HUMAN sample 9606 HOMO SAPIENS 469008 ESCHERICHIA COLI BL21(DE3) 1 2.89 57 5.00 25% PEG 6000, 100MM AMMONIUM SULFATE, 100 MM SODIUM CHLORIDE, 50 MM MES PH 5.0 citation entity_src_gen chem_comp_atom chem_comp_bond database_2 pdbx_database_status pdbx_initial_refinement_model repository Initial release Version format compliance Version format compliance Database references Source and taxonomy Data collection Database references Other Refinement description 1 0 2006-03-29 1 1 2011-05-08 1 2 2011-07-13 1 3 2018-01-31 1 4 2023-12-13 _citation.journal_abbrev _citation.page_last _citation.pdbx_database_id_DOI _citation.title _entity_src_gen.pdbx_host_org_cell_line _entity_src_gen.pdbx_host_org_ncbi_taxonomy_id _entity_src_gen.pdbx_host_org_scientific_name _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.status_code_sf MHC CLASS I MOLECULE B*5301 COMPLEXED WITH PEPTIDETYPDINQML FROM GAG PROTEIN OF HIV2 MHC CLASS I MOLECULE B*3501 COMPLEXED WITH PEPTIDE VPLRPMTYFROM THE NEF PROTEIN (75- 82) OF HIV1 MHC CLASS I MOLECULE B5301 COMPLEXED WITH PEPTIDE LS6 (KPIVQYDNF) FROM THE MALARIA PARASITE P. FALCIPARUM HFE (HUMAN) HEMOCHROMATOSIS PROTEIN DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA-B 3501 DUE TO NONSTANDARD POSITIONING OF THE C-TERMINUS DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA-B 3501 DUE TO NONSTANDARD POSITIONING OF THE C-TERMINUS ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - HIV-1 GAG PEPTIDE (GGRKKYKL - 3R MUTATION) ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - HIV-1 GAG PEPTIDE (GGKKKYQL - 7Q MUTATION) ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - HIV-1 GAG PEPTIDE (GGKKKYKL - INDEX PEPTIDE) ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - HIV-1 GAG PEPTIDE (GGKKKYRL - 7R MUTATION) ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - HIV-1 GAG PEPTIDE (GGKKRYKL - 5R MUTATION) COMPLEX OF THE HUMAN MHC CLASS I GLYCOPROTEIN HLA-A2 ANDTHE T CELL CORECEPTOR CD8 COMPLEX BETWEEN HUMAN T-CELL RECEPTOR, VIRAL PEPTIDE (TAX), AND HLA-A 0201 CRYSTAL STRUCTURE OF HUMAN CLASS I MHC ( HLA-A2.1) COMPLEXED WITH BETA 2- MICROGLOBULIN AND HUMAN PEPTIDE P1049 CRYSTAL STRUCTURE OF HLA-A0201 COMPLEXED WITH A PEPTIDE WITH THE CARBOXYL-TERMINAL GROUP SUBSTITUTED BY A METHYL GROUP COMPLEX BETWEEN HUMAN T-CELL RECEPTOR B7, VIRAL PEPTIDE (TAX) AND MHC CLASS I MOLECULE HLA-A 0201 CRYSTAL STRUCTURE OF MURINE CLASS I MHC H2 -DB COMPLEXED WITH A SYNTHETIC PEPTIDE P1027 CRYSTAL STRUCTURE ANALYSIS OF THE GAMMA/ DELTA T CELL LIGAND T22 MHC CLASS I H-2DB COMPLEXED WITH A SENDAI VIRUSNUCLEOPROTEIN PEPTIDE COMPLEX RECOGNITION OF THE SUPERTYPIC BW6- DETERMINANT ONHLA-B AND-C MOLECULES BY THE MONOCLONAL ANTIBODY SFR8-B6 HEMOCHROMATOSIS PROTEIN HFE COMPLEXED WITH TRANSFERRINRECEPTOR CRYSTAL STRUCTURE OF HLA-A0201/OCTAMERIC TAX PEPTIDE COMPLEX HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA -A 0201) INCOMPLEX WITH A NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN NONSTANDARD PEPTIDE BINDING OF HLA-B*5101 COMPLEXED WITH HIV IMMUNODOMINANT EPITOPE KM1 (LPPVVAKEI) NONSTANDARD PEPTIDE BINDING OF HLA-B*5101 COMPLEXED WITH HIV IMMUNODOMINANT EPITOPE KM2 (TAFTIPSI) CRYSTAL STRUCTURE DETERMINATION OF HLA A2 COMPLEXED TOPEPTIDE GP2 WITH THE SUBSTITUTION (I2L/V5L/L9V) CRYSTAL STRUCTURE DETERMINATION OF HLA-A2.1 COMPLEXED TOGP2 PEPTIDE VARIANT(I2L/V5L) STRUCTURE OF A COMPLEX BETWEEN THE HUMAN NATURAL KILLER CELL RECEPTOR KIR2DL2 AND A CLASS I MHC LIGAND HLA-CW3 CRYSTAL STRUCTURE OF THE HUMAN MHC-RELATED FC RECEPTOR CRYSTAL STRUCTURE OF MURINE CLASS I H-2DB COMPLEXED WITHPEPTIDE GP33(C9M) CRYSTAL STRUCTURE OF MURINE CLASS I H-2DB COMPLEXED WITHSYNTHETIC PEPTIDE GP33 (C9M/ K1A) CRYSTAL STRUCTURE OF MURINE CLASS I H-2DB COMPLEXED WITHPEPTIDE GP33 (C9M/K1S) CRYSTAL STRUCTURE OF THE LCMV PEPTIDIC EPITOPE GP33 INCOMPLEX WITH THE MURINE CLASS I MHC MOLECULE H-2DB CD1B IN COMPLEX WITH GM2 GANGLIOSIDE CD1B IN COMPLEX WITH PHOPHATIDYLINOSITOL MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX CONSISTING OF H-2D==B==, B2- MICROGLOBULIN, AND A 9-RESIDUE PEPTIDE HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA -A 0201) COMPLEX WITH A NONAMERIC PEPTIDE FROM HIV-1 REVERSE TRANSCRIPTASE (RESIDUES 309-317) HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN A2 ( HLA-A2, HUMAN LEUCOCYTE ANTIGEN) HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN HLA- B(ASTERISK)2705 CLASS I HISTOCOMPATIBILITY ANTIGEN AW68.1 ( LEUCOCYTE ANTIGEN) CRYSTAL STRUCTURE OF HUMAN CLASS I MHC ( HLA-A2.1) COMPLEXED WITH BETA 2- MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y CRYSTAL STRUCTURE OF HUMAN CLASS I MHC ( HLA-A2.1) COMPLEXED WITH BETA 2- MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y CRYSTAL STRUCTURE OF HLA-A*0201/MAGE-A4- PEPTIDE COMPLEX CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDEP1058 CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDEP1049-5V CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDEP1049-6V CRYSTAL STRUCTURE OF THE HUMAN CYTOMEGALOVIRUS PROTEIN US2BOUND TO THE MHC CLASS I MOLECULE HLA-A2/TAX CRYSTAL STRUCTURE OF THE HUMAN NATURAL KILLER CELLINHIBITORY RECEPTOR KIR2DL1 BOUND TO ITS MHC LIGAND HLA-CW4 STRUCTURE OF MINOR HISTOCOMPATIBILITY ANTIGEN PEPTIDE, H13A,COMPLEXED TO H2-DB CRYSTAL STRUCTURE OF HLA-A2*0201 IN COMPLEX WITH ADECAMERIC ALTERED PEPTIDE LIGAND FROM THE MART-1/MELAN-A HLA-B*2709 BOUND TO DECA-PEPTIDE S10R HLA-B*2705 BOUND TO NONA-PEPTIDE M9 CRYSTAL STRUCTURE OF HLA-A2*0201 IN COMPLEX WITH ANONAMERIC ALTERED PEPTIDE LIGAND (ALGIGILTV) FROM THE MART-1/MELAN-A. NMR SOLUTION STRUCTURE OF THE HUMAN BETA2- MICROGLOBULIN CRYSTAL STRUCTURE OF THE LCMV PEPTIDIC EPITOPE GP276 INCOMPLEX WITH THE MURINE CLASS I MHC MOLECULE H-2DB CRYSTAL STRUCTURE OF THE LCMV PEPTIDIC EPITOPE NP396 INCOMPLEX WITH THE MURINE CLASS I MHC MOLECULE H-2DB STRUCTURE OF MINOR HISTOCOMPATIBILITY ANTIGEN PEPTIDE, H13B,COMPLEXED TO H2-DB HLA-B*2709 BOUND TO NONA-PEPTIDE M9 THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEXMOLECULE HLA-E THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEXMOLECULE HLA-E CRYSTAL STRUCTURE OF MONOMERIC HUMAN BETA-2 -MICROGLOBULIN XENOREACTIVE COMPLEX AHIII 12.2 TCR BOUND TO P1049/HLA-A2.1 HLA B8 IN COMPLEX WITH AN EPSTEIN BARR VIRUS DETERMINANT CRYSTAL STRUCTURE OF HLA B*4402 IN COMPLEX WITH HLADPA*0201 PEPTIDE THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E THE CRYSTAL STRUCTURE OF LC13 TCR IN COMPLEX WITH HLAB8-EBVPEPTIDE COMPLEX A NATURAL SELECTED DIMORPHISM IN HLA B*44 ALTERS SELF,PEPTIDE REPORTOIRE AND T CELL RECOGNITION. CRYSTAL STRUCTURE OF A MYCOBACTERIAL HSP60 EPITOPE WITH THEMURINE CLASS I MHC MOLECULE H-2DB CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJORHISTOCOMPATIBILITY COMPLEX OF H-2DB, B2- MICROGLOBULIN, ANDA 9-RESIDUE IMMUNODOMINANT PEPTIDE EPITOPE GP33 DERIVEDFROM LCMV CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VPAC1) PEPTIDE (RESIDUES 400-408 ) A STRUCTURAL BASIS FOR IMMUNODOMINANT HUMAN T-CELL RECEPTOR RECOGNITION. CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VPAC1) PEPTIDE (RESIDUES 400-408 ) CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH A SULFATIDE CRYSTAL STRUCTURE OF HLA-A2 BOUND TO LIR- 1, A HOST ANDVIRAL MHC RECEPTOR BETA2 MICROGLOBULIN MUTANT H31Y DISPLAYS HINTS FOR AMYLOIDFORMATIONS STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANTNONAMER AND DECAMER HIV-1 EPITOPES CLEARLY REVEAL THEPRESENCE OF A MIDDLE ANCHOR RESIDUE HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA -A 0201)COMPLEX WITH A NONAMERIC PEPTIDE FROM MELANOMA-ASSOCIATEDANTIGEN 3 (RESIDUES 271-279) MHC CLASS I H-2DB COMPLEXED WITH GLYCOPEPTIDE K3G CRYSTAL STRUCTURE OF HLA-CW4, A LIGAND FOR THE KIR2D NATURAL KILLER CELL INHIBITORY RECEPTOR POOR BINDING OF A HER-2/NEU EPITOPE (GP2 ) TO HLA-A2.1 IS DUE TO A LACK OF INTERACTIONS IN THE CENTER OF THE PEPTIDE CRYSTAL STRUCTURE OF HUMAN A6 TCR COMPLEXED WITH HLA-A2 BOUND TO ALTERED HTLV-1 TAX PEPTIDE P6A STRUCTURE OF HUMAN A6-TCR BOUND TO HLA- A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE V7R STRUCTURE OF A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE Y8A STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANTNONAMER AND DECAMER HIV-1 EPITOPES CLEARLY REVEAL THEPRESENCE OF A MIDDLE ANCHOR RESIDUE CRYSTAL STRUCTURE OF T10 CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJORHISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJORHISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJORHISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJORHISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE, SLLMWITQC,IN COMPLEX WITH HLA-A2 CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE ANALOGUE,SLLMWITQA, IN COMPLEX WITH HLA-A2 CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE ANALOGUE,SLLMWITQS, IN COMPLEX WITH HLA-A2 CRYSTAL STRUCTURE OF HLA, B*4403, AND PEPTIDE EEPTVIKKY HLA-B*4405 COMPLEXED TO THE DOMINANT SELF LIGAND EEFGRAYGF TRUNCATED HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN HLA-AW68 COMPLEXED WITH A DECAMERIC PEPTIDE (EVAPPEYHRK) CRYSTAL STRUCTURE OF MELANOMA ANTIGEN GP100( 209-217) BOUNDTO HUMAN CLASS I MHC HLA- A2 CRYSTAL STRUCTURE OF MODIFIED MELANOMA ANTIGEN GP100(209-T2M) BOUND TO HUMAN CLASS I MHC HLA-A2 THE CRYSTAL STRUCTURE OF HUMAN CD1B WITH A BOUND BACTERIAL GLYCOLIPID MOLECULAR REFINEMENT OF ANTI-HLA-A2 USING LIGHT CHAIN SHUFFLING: A STRUCTURAL MODEL FOR HLA ANTIBODY BINDING CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2)OF EPSTEIN-BARR VIRUS CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2) OF EPSTEIN-BARR VIRUS THE CRYSTAL STRUCTURE OF CLASS I MAJOR HISTOCOMPATIBILITYCOMPLEX, H-2KD AT 2.0 A RESOLUTION CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE SELF-PEPTIDE TIS FROM EGF- RESPONSE FACTOR 1 CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE SELF-PEPTIDE TIS FROM EGF- RESPONSE FACTOR 1 CRYSTAL STRUCTURE OF HLA-A1:MAGE-A1 IN COMPLEX WITH FAB-HYB3 CRYSTAL STRUCTURES OF MURINE MHC CLASS I H -2 DB AND KB MOLECULES IN COMPLEX WITH CTL EPITOPES FROM INFLUENZA A VIRUS: IMPLICATIONS FOR TCR REPERTOIRE SELECTION AND IMMUNODOMINANCE CRYSTAL STRUCTURES OF MURINE MHC CLASS I H -2 DB AND KB MOLECULES IN COMPLEX WITH CTL EPITOPES FROM INFLUENZA A VIRUS: IMPLICATIONS FOR TCR REPERTOIRE SELECTION AND IMMUNODOMINANCE CRYSTAL STRUCTURE OF HLA-A*1101 WITH SARS NUCLEOCAPSIDPEPTIDE CONFORMATIONAL RESTRAINTS AND FLEXIBILITY OF 14-MERICPEPTIDES IN COMPLEX WITH HLA-B* 3501 CRYSTAL STRUCTURES OF HLA-B*1501 IN COMPLEX WITH PEPTIDESFROM HUMAN UBCH6 AND EPSTEIN-BARR VIRUS EBNA-3 CRYSTAL STRUCTURES OF HLA-B*1501 IN COMPLEX WITH PEPTIDESFROM HUMAN UBCH6 AND EPSTEIN-BARR VIRUS EBNA-3 CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH A SYNTHETICMYCOBACTIN LIPOPEPTIDE CRYSTAL STRUCTURE OF A MOUSE MHC CLASS I PROTEIN, H2-DB, INCOMPLEX WITH A PEPTIDE FROM THE INFLUENZA A ACID POLYMERASE CRYSTAL STRUCTURE OF A MOUSE MHC CLASS I PROTEIN, H2-DB, INCOMPLEX WITH A MUTATED PEPTIDE (R7A) OF THE INFLUENZA AACID POLYMERASE 1.9A CRYSTAL STRUCTURE OF HLA-G IMMUNE RECEPTOR CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJORHISTOCOMPATIBILITY COMPLEX OF H-2DB, B2- MICROGLOBULIN, ANDA 9-RESIDUE PEPTIDE DERIVED FROM RAT DOPAMINE BETA-MONOOXIGENASE CRYSTAL STRUCTURE OF THE MURINE MHC CLASS IB MOLECULE M10.5 CRYSTAL STRUCTURE OF HLA-B*3501 PRESENTING AN 11-MER EBVANTIGEN EPLPQGQLTAY THE CRYSTAL STRUCTURE OF HUMAN CD1D WITH AND WITHOUT ALPHA-GALACTOSYLCERAMIDE CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE GLUCAGONRECEPTOR (GR) PEPTIDE ( RESIDUES 412-420) CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B*3508-13MER PEPTIDE CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMANCLASS I MHC HLA-A2 WITH THE K66A MUTATION IN THE HEAVYCHAIN. THE IMMUNOGENICITY OF A VIRAL CYTOTOXIC T CELL EPITOPE ISCONTROLLED BY ITS MHC-BOUND CONFORMATION THE IMMUNOGENICITY OF A VIRAL CYTOTOXIC T CELL EPITOPE ISCONTROLLED BY ITS MHC-BOUND CONFORMATION CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A TELOMERASEPEPTIDE STRUCTURAL AND KINETIC BASIS FOR HIGHTENED IMMUNOGENICITY OF T CELL VACCINES STRUCTURAL AND KINETIC BASIS FOR HIGHTENED IMMUNOGENICITY OF T CELL VACCINES CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO HLA-B2705 CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO HLA-B2705 CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO HLA-B2705 T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT STRUCTURES OF THREE HIV-1 HLA-B5703- PEPTIDE COMPLEXES AND IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG -TERM NON-PROGRESSION CONFLICTING SELECTIVE FORCES AFFECT CD8 T- CELL RECEPTOR CONTACT SITES IN AN HLA-A2 IMMUNODOMINANT HIV EPITOPE. INSIGHTS INTO CROSSREACTIVITY IN HUMAN ALLORECOGNITION: THE STRUCTURE OF HLA-B35011 PRESENTING AN EPITOPE DERIVED FROM CYTOCHROME P450. HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA -A 0201) COMPLEXED WITH A DECAMERIC PEPTIDE FROM CALRETICULIN CRYSTAL STRUCTURE OF DISULFIDE-LINKED HLA-G DIMER MURINE MHC CLASS I H-2DB IN COMPLEX WITH HUMAN B2-MICROGLOBULIN AND LCMV-DERIVED IMMUNODMINANT PEPTIDE GP33 A NATIVE TO AMYLOIDOGENIC TRANSITION REGULATED BY ABACKBONE TRIGGER HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN AW 68.1 (HLA-AW 68.1, HUMAN LEUCOCYTE ANTIGEN) HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN A2. 1 (HLA-A2.1 HUMAN LEUCOCYTE ANTIGEN) SHEET THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, TWO SHEETS ARE DEFINED. PDBE Y PDBE 2006-03-21 REL REL GOL GLYCEROL HOH water 12730 HUMAN PARAINFLUENZA 1 VIRUS sample INVOLVED IN THE PRESENTATION OF FOREIGN ANTIGENS TO THE IMMUNE SYSTEM BETA-2-MICROGLOBULIN IS THE BETA-CHAIN OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I MOLECULES 1CE6 PDB ENTRY 1CE6 PDB experimental model GOL 1276 4 GOL GOL 1276 A GOL 1277 4 GOL GOL 1277 A HOH 2001 5 HOH HOH 2001 A HOH 2002 5 HOH HOH 2002 A HOH 2003 5 HOH HOH 2003 A HOH 2004 5 HOH HOH 2004 A HOH 2005 5 HOH HOH 2005 A HOH 2006 5 HOH HOH 2006 A HOH 2007 5 HOH HOH 2007 A HOH 2008 5 HOH HOH 2008 A HOH 2009 5 HOH HOH 2009 A HOH 2010 5 HOH HOH 2010 A HOH 2011 5 HOH HOH 2011 A HOH 2012 5 HOH HOH 2012 A HOH 2013 5 HOH HOH 2013 A HOH 2014 5 HOH HOH 2014 A HOH 2015 5 HOH HOH 2015 A HOH 2016 5 HOH HOH 2016 A HOH 2017 5 HOH HOH 2017 A HOH 2018 5 HOH HOH 2018 A HOH 2019 5 HOH HOH 2019 A HOH 2020 5 HOH HOH 2020 A HOH 2021 5 HOH HOH 2021 A HOH 2022 5 HOH HOH 2022 A HOH 2023 5 HOH HOH 2023 A HOH 2024 5 HOH HOH 2024 A HOH 2025 5 HOH HOH 2025 A HOH 2026 5 HOH HOH 2026 A HOH 2027 5 HOH HOH 2027 A HOH 2028 5 HOH HOH 2028 A HOH 2029 5 HOH HOH 2029 A HOH 2030 5 HOH HOH 2030 A HOH 2031 5 HOH HOH 2031 A HOH 2032 5 HOH HOH 2032 A HOH 2033 5 HOH HOH 2033 A HOH 2034 5 HOH HOH 2034 A HOH 2035 5 HOH HOH 2035 A HOH 2036 5 HOH HOH 2036 A HOH 2037 5 HOH HOH 2037 A HOH 2038 5 HOH HOH 2038 A HOH 2039 5 HOH HOH 2039 A HOH 2040 5 HOH HOH 2040 A HOH 2041 5 HOH HOH 2041 A HOH 2042 5 HOH HOH 2042 A HOH 2043 5 HOH HOH 2043 A HOH 2044 5 HOH HOH 2044 A HOH 2045 5 HOH HOH 2045 A HOH 2046 5 HOH HOH 2046 A HOH 2047 5 HOH HOH 2047 A HOH 2048 5 HOH HOH 2048 A HOH 2049 5 HOH HOH 2049 A HOH 2050 5 HOH HOH 2050 A HOH 2051 5 HOH HOH 2051 A HOH 2052 5 HOH HOH 2052 A HOH 2053 5 HOH HOH 2053 A HOH 2054 5 HOH HOH 2054 A HOH 2055 5 HOH HOH 2055 A HOH 2001 5 HOH HOH 2001 B HOH 2002 5 HOH HOH 2002 B HOH 2003 5 HOH HOH 2003 B HOH 2004 5 HOH HOH 2004 B HOH 2005 5 HOH HOH 2005 B HOH 2006 5 HOH HOH 2006 B HOH 2007 5 HOH HOH 2007 B HOH 2008 5 HOH HOH 2008 B HOH 2009 5 HOH HOH 2009 B HOH 2010 5 HOH HOH 2010 B HOH 2011 5 HOH HOH 2011 B HOH 2012 5 HOH HOH 2012 B HOH 2013 5 HOH HOH 2013 B HOH 2014 5 HOH HOH 2014 B HOH 2015 5 HOH HOH 2015 B HOH 2016 5 HOH HOH 2016 B HOH 2017 5 HOH HOH 2017 B HOH 2018 5 HOH HOH 2018 B HOH 2019 5 HOH HOH 2019 B HOH 2020 5 HOH HOH 2020 B HOH 2021 5 HOH HOH 2021 B HOH 2022 5 HOH HOH 2022 B HOH 2023 5 HOH HOH 2023 B HOH 2024 5 HOH HOH 2024 B HOH 2025 5 HOH HOH 2025 B HOH 2026 5 HOH HOH 2026 B HOH 2027 5 HOH HOH 2027 B HOH 2028 5 HOH HOH 2028 B HOH 2029 5 HOH HOH 2029 B HOH 2030 5 HOH HOH 2030 B HOH 2031 5 HOH HOH 2031 B HOH 2032 5 HOH HOH 2032 B HOH 2033 5 HOH HOH 2033 B HOH 2034 5 HOH HOH 2034 B HOH 2035 5 HOH HOH 2035 B HOH 2036 5 HOH HOH 2036 B HOH 2037 5 HOH HOH 2037 B HOH 2038 5 HOH HOH 2038 B HOH 2039 5 HOH HOH 2039 B HOH 2040 5 HOH HOH 2040 B HOH 2041 5 HOH HOH 2041 B HOH 2042 5 HOH HOH 2042 B HOH 2043 5 HOH HOH 2043 B HOH 2044 5 HOH HOH 2044 B HOH 2045 5 HOH HOH 2045 B HOH 2001 5 HOH HOH 2001 C GLY 1 n 1 GLY 1 A PRO 2 n 2 PRO 2 A HIS 3 n 3 HIS 3 A SER 4 n 4 SER 4 A MET 5 n 5 MET 5 A ARG 6 n 6 ARG 6 A TYR 7 n 7 TYR 7 A PHE 8 n 8 PHE 8 A GLU 9 n 9 GLU 9 A THR 10 n 10 THR 10 A ALA 11 n 11 ALA 11 A VAL 12 n 12 VAL 12 A SER 13 n 13 SER 13 A ARG 14 n 14 ARG 14 A PRO 15 n 15 PRO 15 A GLY 16 n 16 GLY 16 A LEU 17 n 17 LEU 17 A GLU 18 n 18 GLU 18 A GLU 19 n 19 GLU 19 A PRO 20 n 20 PRO 20 A ARG 21 n 21 ARG 21 A TYR 22 n 22 TYR 22 A ILE 23 n 23 ILE 23 A SER 24 n 24 SER 24 A VAL 25 n 25 VAL 25 A GLY 26 n 26 GLY 26 A TYR 27 n 27 TYR 27 A VAL 28 n 28 VAL 28 A ASP 29 n 29 ASP 29 A ASN 30 n 30 ASN 30 A LYS 31 n 31 LYS 31 A GLU 32 n 32 GLU 32 A PHE 33 n 33 PHE 33 A VAL 34 n 34 VAL 34 A ARG 35 n 35 ARG 35 A PHE 36 n 36 PHE 36 A ASP 37 n 37 ASP 37 A SER 38 n 38 SER 38 A ASP 39 n 39 ASP 39 A ALA 40 n 40 ALA 40 A GLU 41 n 41 GLU 41 A ASN 42 n 42 ASN 42 A PRO 43 n 43 PRO 43 A ARG 44 n 44 ARG 44 A TYR 45 n 45 TYR 45 A GLU 46 n 46 GLU 46 A PRO 47 n 47 PRO 47 A ARG 48 n 48 ARG 48 A ALA 49 n 49 ALA 49 A PRO 50 n 50 PRO 50 A TRP 51 n 51 TRP 51 A MET 52 n 52 MET 52 A GLU 53 n 53 GLU 53 A GLN 54 n 54 GLN 54 A GLU 55 n 55 GLU 55 A GLY 56 n 56 GLY 56 A PRO 57 n 57 PRO 57 A GLU 58 n 58 GLU 58 A TYR 59 n 59 TYR 59 A TRP 60 n 60 TRP 60 A GLU 61 n 61 GLU 61 A ARG 62 n 62 ARG 62 A GLU 63 n 63 GLU 63 A THR 64 n 64 THR 64 A GLN 65 n 65 GLN 65 A LYS 66 n 66 LYS 66 A ALA 67 n 67 ALA 67 A LYS 68 n 68 LYS 68 A GLY 69 n 69 GLY 69 A GLN 70 n 70 GLN 70 A GLU 71 n 71 GLU 71 A GLN 72 n 72 GLN 72 A TRP 73 n 73 TRP 73 A PHE 74 n 74 PHE 74 A ARG 75 n 75 ARG 75 A VAL 76 n 76 VAL 76 A SER 77 n 77 SER 77 A LEU 78 n 78 LEU 78 A ARG 79 n 79 ARG 79 A ASN 80 n 80 ASN 80 A LEU 81 n 81 LEU 81 A LEU 82 n 82 LEU 82 A GLY 83 n 83 GLY 83 A TYR 84 n 84 TYR 84 A TYR 85 n 85 TYR 85 A ASN 86 n 86 ASN 86 A GLN 87 n 87 GLN 87 A SER 88 n 88 SER 88 A ALA 89 n 89 ALA 89 A GLY 90 n 90 GLY 90 A GLY 91 n 91 GLY 91 A SER 92 n 92 SER 92 A HIS 93 n 93 HIS 93 A THR 94 n 94 THR 94 A LEU 95 n 95 LEU 95 A GLN 96 n 96 GLN 96 A GLN 97 n 97 GLN 97 A MET 98 n 98 MET 98 A SER 99 n 99 SER 99 A GLY 100 n 100 GLY 100 A CYS 101 n 101 CYS 101 A ASP 102 n 102 ASP 102 A LEU 103 n 103 LEU 103 A GLY 104 n 104 GLY 104 A SER 105 n 105 SER 105 A ASP 106 n 106 ASP 106 A TRP 107 n 107 TRP 107 A ARG 108 n 108 ARG 108 A LEU 109 n 109 LEU 109 A LEU 110 n 110 LEU 110 A ARG 111 n 111 ARG 111 A GLY 112 n 112 GLY 112 A TYR 113 n 113 TYR 113 A LEU 114 n 114 LEU 114 A GLN 115 n 115 GLN 115 A PHE 116 n 116 PHE 116 A ALA 117 n 117 ALA 117 A TYR 118 n 118 TYR 118 A GLU 119 n 119 GLU 119 A GLY 120 n 120 GLY 120 A ARG 121 n 121 ARG 121 A ASP 122 n 122 ASP 122 A TYR 123 n 123 TYR 123 A ILE 124 n 124 ILE 124 A ALA 125 n 125 ALA 125 A LEU 126 n 126 LEU 126 A ASN 127 n 127 ASN 127 A GLU 128 n 128 GLU 128 A ASP 129 n 129 ASP 129 A LEU 130 n 130 LEU 130 A LYS 131 n 131 LYS 131 A THR 132 n 132 THR 132 A TRP 133 n 133 TRP 133 A THR 134 n 134 THR 134 A ALA 135 n 135 ALA 135 A ALA 136 n 136 ALA 136 A ASP 137 n 137 ASP 137 A MET 138 n 138 MET 138 A ALA 139 n 139 ALA 139 A ALA 140 n 140 ALA 140 A GLN 141 n 141 GLN 141 A ILE 142 n 142 ILE 142 A THR 143 n 143 THR 143 A ARG 144 n 144 ARG 144 A ARG 145 n 145 ARG 145 A LYS 146 n 146 LYS 146 A TRP 147 n 147 TRP 147 A GLU 148 n 148 GLU 148 A GLN 149 n 149 GLN 149 A SER 150 n 150 SER 150 A GLY 151 n 151 GLY 151 A ALA 152 n 152 ALA 152 A ALA 153 n 153 ALA 153 A GLU 154 n 154 GLU 154 A HIS 155 n 155 HIS 155 A TYR 156 n 156 TYR 156 A LYS 157 n 157 LYS 157 A ALA 158 n 158 ALA 158 A TYR 159 n 159 TYR 159 A LEU 160 n 160 LEU 160 A GLU 161 n 161 GLU 161 A GLY 162 n 162 GLY 162 A GLU 163 n 163 GLU 163 A CYS 164 n 164 CYS 164 A VAL 165 n 165 VAL 165 A GLU 166 n 166 GLU 166 A TRP 167 n 167 TRP 167 A LEU 168 n 168 LEU 168 A HIS 169 n 169 HIS 169 A ARG 170 n 170 ARG 170 A TYR 171 n 171 TYR 171 A LEU 172 n 172 LEU 172 A LYS 173 n 173 LYS 173 A ASN 174 n 174 ASN 174 A GLY 175 n 175 GLY 175 A ASN 176 n 176 ASN 176 A ALA 177 n 177 ALA 177 A THR 178 n 178 THR 178 A LEU 179 n 179 LEU 179 A LEU 180 n 180 LEU 180 A ARG 181 n 181 ARG 181 A THR 182 n 182 THR 182 A ASP 183 n 183 ASP 183 A SER 184 n 184 SER 184 A PRO 185 n 185 PRO 185 A LYS 186 n 186 LYS 186 A ALA 187 n 187 ALA 187 A HIS 188 n 188 HIS 188 A VAL 189 n 189 VAL 189 A THR 190 n 190 THR 190 A HIS 191 n 191 HIS 191 A HIS 192 n 192 HIS 192 A PRO 193 n 193 PRO 193 A ARG 194 n 194 ARG 194 A SER 195 n 195 SER 195 A LYS 196 n 196 LYS 196 A GLY 197 n 197 GLY 197 A GLU 198 n 198 GLU 198 A VAL 199 n 199 VAL 199 A THR 200 n 200 THR 200 A LEU 201 n 201 LEU 201 A ARG 202 n 202 ARG 202 A CYS 203 n 203 CYS 203 A TRP 204 n 204 TRP 204 A ALA 205 n 205 ALA 205 A LEU 206 n 206 LEU 206 A GLY 207 n 207 GLY 207 A PHE 208 n 208 PHE 208 A TYR 209 n 209 TYR 209 A PRO 210 n 210 PRO 210 A ALA 211 n 211 ALA 211 A ASP 212 n 212 ASP 212 A ILE 213 n 213 ILE 213 A THR 214 n 214 THR 214 A LEU 215 n 215 LEU 215 A THR 216 n 216 THR 216 A TRP 217 n 217 TRP 217 A ALA 218 n 218 ALA 218 A LEU 219 n 219 LEU 219 A ASN 220 n 220 ASN 220 A GLY 221 n 221 GLY 221 A GLU 222 n 222 GLU 222 A GLU 223 n 223 GLU 223 A LEU 224 n 224 LEU 224 A THR 225 n 225 THR 225 A GLN 226 n 226 GLN 226 A ASP 227 n 227 ASP 227 A MET 228 n 228 MET 228 A GLU 229 n 229 GLU 229 A LEU 230 n 230 LEU 230 A VAL 231 n 231 VAL 231 A GLU 232 n 232 GLU 232 A THR 233 n 233 THR 233 A ARG 234 n 234 ARG 234 A PRO 235 n 235 PRO 235 A ALA 236 n 236 ALA 236 A GLY 237 n 237 GLY 237 A ASP 238 n 238 ASP 238 A GLY 239 n 239 GLY 239 A THR 240 n 240 THR 240 A PHE 241 n 241 PHE 241 A GLN 242 n 242 GLN 242 A LYS 243 n 243 LYS 243 A TRP 244 n 244 TRP 244 A ALA 245 n 245 ALA 245 A SER 246 n 246 SER 246 A VAL 247 n 247 VAL 247 A VAL 248 n 248 VAL 248 A VAL 249 n 249 VAL 249 A PRO 250 n 250 PRO 250 A LEU 251 n 251 LEU 251 A GLY 252 n 252 GLY 252 A LYS 253 n 253 LYS 253 A GLU 254 n 254 GLU 254 A GLN 255 n 255 GLN 255 A ASN 256 n 256 ASN 256 A TYR 257 n 257 TYR 257 A THR 258 n 258 THR 258 A CYS 259 n 259 CYS 259 A ARG 260 n 260 ARG 260 A VAL 261 n 261 VAL 261 A TYR 262 n 262 TYR 262 A HIS 263 n 263 HIS 263 A GLU 264 n 264 GLU 264 A GLY 265 n 265 GLY 265 A LEU 266 n 266 LEU 266 A PRO 267 n 267 PRO 267 A GLU 268 n 268 GLU 268 A PRO 269 n 269 PRO 269 A LEU 270 n 270 LEU 270 A THR 271 n 271 THR 271 A LEU 272 n 272 LEU 272 A ARG 273 n 273 ARG 273 A TRP 274 n 274 TRP 274 A GLU 275 n 275 GLU 275 A ILE 1 n 1 ILE 1 B GLN 2 n 2 GLN 2 B ARG 3 n 3 ARG 3 B THR 4 n 4 THR 4 B PRO 5 n 5 PRO 5 B LYS 6 n 6 LYS 6 B ILE 7 n 7 ILE 7 B GLN 8 n 8 GLN 8 B VAL 9 n 9 VAL 9 B TYR 10 n 10 TYR 10 B SER 11 n 11 SER 11 B ARG 12 n 12 ARG 12 B HIS 13 n 13 HIS 13 B PRO 14 n 14 PRO 14 B ALA 15 n 15 ALA 15 B GLU 16 n 16 GLU 16 B ASN 17 n 17 ASN 17 B GLY 18 n 18 GLY 18 B LYS 19 n 19 LYS 19 B SER 20 n 20 SER 20 B ASN 21 n 21 ASN 21 B PHE 22 n 22 PHE 22 B LEU 23 n 23 LEU 23 B ASN 24 n 24 ASN 24 B CYS 25 n 25 CYS 25 B TYR 26 n 26 TYR 26 B VAL 27 n 27 VAL 27 B SER 28 n 28 SER 28 B GLY 29 n 29 GLY 29 B PHE 30 n 30 PHE 30 B HIS 31 n 31 HIS 31 B PRO 32 n 32 PRO 32 B SER 33 n 33 SER 33 B ASP 34 n 34 ASP 34 B ILE 35 n 35 ILE 35 B GLU 36 n 36 GLU 36 B VAL 37 n 37 VAL 37 B ASP 38 n 38 ASP 38 B LEU 39 n 39 LEU 39 B LEU 40 n 40 LEU 40 B LYS 41 n 41 LYS 41 B ASN 42 n 42 ASN 42 B GLY 43 n 43 GLY 43 B GLU 44 n 44 GLU 44 B ARG 45 n 45 ARG 45 B ILE 46 n 46 ILE 46 B GLU 47 n 47 GLU 47 B LYS 48 n 48 LYS 48 B VAL 49 n 49 VAL 49 B GLU 50 n 50 GLU 50 B HIS 51 n 51 HIS 51 B SER 52 n 52 SER 52 B ASP 53 n 53 ASP 53 B LEU 54 n 54 LEU 54 B SER 55 n 55 SER 55 B PHE 56 n 56 PHE 56 B SER 57 n 57 SER 57 B LYS 58 n 58 LYS 58 B ASP 59 n 59 ASP 59 B TRP 60 n 60 TRP 60 B SER 61 n 61 SER 61 B PHE 62 n 62 PHE 62 B TYR 63 n 63 TYR 63 B LEU 64 n 64 LEU 64 B LEU 65 n 65 LEU 65 B TYR 66 n 66 TYR 66 B TYR 67 n 67 TYR 67 B THR 68 n 68 THR 68 B GLU 69 n 69 GLU 69 B PHE 70 n 70 PHE 70 B THR 71 n 71 THR 71 B PRO 72 n 72 PRO 72 B THR 73 n 73 THR 73 B GLU 74 n 74 GLU 74 B LYS 75 n 75 LYS 75 B ASP 76 n 76 ASP 76 B GLU 77 n 77 GLU 77 B TYR 78 n 78 TYR 78 B ALA 79 n 79 ALA 79 B CYS 80 n 80 CYS 80 B ARG 81 n 81 ARG 81 B VAL 82 n 82 VAL 82 B ASN 83 n 83 ASN 83 B HIS 84 n 84 HIS 84 B VAL 85 n 85 VAL 85 B THR 86 n 86 THR 86 B LEU 87 n 87 LEU 87 B SER 88 n 88 SER 88 B GLN 89 n 89 GLN 89 B PRO 90 n 90 PRO 90 B LYS 91 n 91 LYS 91 B ILE 92 n 92 ILE 92 B VAL 93 n 93 VAL 93 B LYS 94 n 94 LYS 94 B TRP 95 n 95 TRP 95 B ASP 96 n 96 ASP 96 B ARG 97 n 97 ARG 97 B ASP 98 n 98 ASP 98 B MET 99 n 99 MET 99 B n 1 1 C n 2 2 C n 3 3 C n 4 4 C n 5 5 C TYR 6 n 6 TYR 6 C PRO 7 n 7 PRO 7 C ALA 8 n 8 ALA 8 C LEU 9 n 9 LEU 9 C author_and_software_defined_assembly PQS 3 trimeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N GLU 46 A N GLU 46 A O ARG 35 A O ARG 35 A N PHE 36 A N PHE 36 A O SER 24 A O SER 24 A N TYR 27 A N TYR 27 A O ARG 6 A O ARG 6 A N ALA 11 A N ALA 11 A O LEU 95 A O LEU 95 A O ASP 102 A O ASP 102 A N LEU 110 A N LEU 110 A N TYR 118 A N TYR 118 A O ARG 121 A O ARG 121 A N ALA 125 A N ALA 125 A O THR 134 A O THR 134 A N ARG 194 A N ARG 194 A O GLU 198 A O GLU 198 A N PHE 208 A N PHE 208 A O PHE 241 A O PHE 241 A N SER 246 A N SER 246 A O GLU 229 A O GLU 229 A N ARG 194 A N ARG 194 A O GLU 198 A O GLU 198 A N PHE 208 A N PHE 208 A O PHE 241 A O PHE 241 A N GLN 242 A N GLN 242 A O ARG 234 A O ARG 234 A N GLU 222 A N GLU 222 A O LEU 219 A O LEU 219 A N ALA 218 A N ALA 218 A O THR 258 A O THR 258 A N VAL 261 A N VAL 261 A O LEU 270 A O LEU 270 B N TYR 10 B N TYR 10 B O ASN 24 B O ASN 24 B N PHE 30 B N PHE 30 B O PHE 62 B O PHE 62 B N TYR 67 B N TYR 67 B O GLU 50 B O GLU 50 B N TYR 10 B N TYR 10 B O ASN 24 B O ASN 24 B N PHE 30 B N PHE 30 B O PHE 62 B O PHE 62 B N TYR 63 B N TYR 63 B O SER 55 B O SER 55 B N GLU 44 B N GLU 44 B O LYS 41 B O LYS 41 B N LEU 40 B N LEU 40 B O ALA 79 B O ALA 79 B N VAL 82 B N VAL 82 B O LYS 91 B O LYS 91 1 C PHE 1 C PHE 1 1 Y 1 C ALA 2 C ALA 2 1 Y 1 C PRO 3 C PRO 3 1 Y 1 C GLY 4 C GLY 4 1 Y 1 C ASN 5 C ASN 5 1 Y 1 A GLU 18 -69.53 30.01 1 A ASP 29 44.69 29.11 1 A GLU 41 -45.54 -71.53 1 A ARG 44 -170.46 145.84 1 A TYR 84 -38.87 -37.99 1 A SER 88 -71.05 -139.39 1 A LYS 131 -151.30 -22.98 1 A ASN 220 47.08 -96.82 1 A ASP 227 39.39 44.57 1 B ALA 15 -47.95 153.68 1 B GLU 16 -161.16 111.29 1 B ASN 21 -139.44 -158.90 1 B PRO 32 -67.70 -178.07 1 B TRP 60 80.57 -6.80 PROTEIN_REP.PARAM WATER_REP.PARAM CARBOHYDRATE.PARAM GOL.PAR 34.545 11.203 0.000 -3.894 10.317 0.000 -21.520 0.2969 0.2391 0.2391 2.55 20 1232 15697 7.5 96.2 RANDOM 10000 1 THROUGHOUT 0.0 MOLECULAR REPLACEMENT PDB ENTRY 1CE6 30.0534 0.349682 0.45 0.36 0.42 0.27 2.55 20 101 3229 12 0 3116 0.007055 1.33067 25.15332 0.76967 1.355 2.305 1.810 2.748 0.3906 0.2933 2.64 128 1448 10 8.8 97.2 2.550 30.000 2CII 15880 1.000 0.05000 1 19.8000 2.500 95.8 0.16000 2.55 2.61 5.300 1 96.9 data reduction DENZO data scaling SCALEPACK phasing X-PLOR phasing CNS refinement CNS 0.9 The crystal structure of H-2Db complexed with a partial peptide epitope suggests an MHC Class I assembly-intermediate 1 N N 2 N N 3 N N 4 N N 4 N N 5 N N 5 N N 5 N N A ALA 49 A ALA 49 HELX_P A GLU 53 A GLU 53 5 1 5 A GLY 56 A GLY 56 HELX_P A TYR 85 A TYR 85 1 2 30 A ASP 137 A ASP 137 HELX_P A GLY 151 A GLY 151 1 3 15 A GLY 151 A GLY 151 HELX_P A GLY 162 A GLY 162 1 4 12 A GLY 162 A GLY 162 HELX_P A GLY 175 A GLY 175 1 5 14 A GLY 175 A GLY 175 HELX_P A LEU 180 A LEU 180 1 6 6 A LYS 253 A LYS 253 HELX_P A GLN 255 A GLN 255 5 7 3 disulf 2.041 A CYS 101 A SG CYS 101 1_555 A CYS 164 A SG CYS 164 1_555 disulf 2.023 A CYS 203 A SG CYS 203 1_555 A CYS 259 A SG CYS 259 1_555 disulf 2.037 B CYS 25 B SG CYS 25 1_555 B CYS 80 B SG CYS 80 1_555 IMMUNE SYSTEM/PEPTIDE IMMUNE SYSTEM/PEPTIDE, COMPLEX (ANTIGEN-PEPTIDE), MHC CLASS I, PEPTIDE BINDING, SENDAI VIRUS, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I, PYRROLIDONE CARBOXYLIC ACID, GLYCOPROTEIN, MEMBRANE, TRANSMEMBRANE, IMMUNE SYSTEM-PEPTIDE complex A GLY 1 A GLY 1 1 A PRO 2 A PRO 2 0.04 A TYR 209 A TYR 209 1 A PRO 210 A PRO 210 0.73 B HIS 31 B HIS 31 1 B PRO 32 B PRO 32 0.07 HA11_MOUSE UNP 1 P01899 B2MG_HUMAN UNP 2 P61769 NCAP_PI1HW UNP 3 P26590 25 299 2CII 1 275 P01899 A 1 1 275 21 119 2CII 1 99 P61769 B 2 1 99 324 332 2CII 1 9 P26590 C 3 1 9 1 GLN conflict ALA 218 2CII A P01899 UNP 242 218 8 4 4 4 4 4 4 anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel A GLU 46 A GLU 46 A PRO 47 A PRO 47 A LYS 31 A LYS 31 A ASP 37 A ASP 37 A LEU 17 A LEU 17 A VAL 28 A VAL 28 A HIS 3 A HIS 3 A ARG 14 A ARG 14 A THR 94 A THR 94 A LEU 103 A LEU 103 A LEU 109 A LEU 109 A TYR 118 A TYR 118 A ARG 121 A ARG 121 A LEU 126 A LEU 126 A TRP 133 A TRP 133 A ALA 135 A ALA 135 A LYS 186 A LYS 186 A SER 195 A SER 195 A GLU 198 A GLU 198 A PHE 208 A PHE 208 A PHE 241 A PHE 241 A PRO 250 A PRO 250 A MET 228 A MET 228 A LEU 230 A LEU 230 A LYS 186 A LYS 186 A SER 195 A SER 195 A GLU 198 A GLU 198 A PHE 208 A PHE 208 A PHE 241 A PHE 241 A PRO 250 A PRO 250 A ARG 234 A ARG 234 A PRO 235 A PRO 235 A GLU 222 A GLU 222 A GLU 223 A GLU 223 A THR 214 A THR 214 A LEU 219 A LEU 219 A TYR 257 A TYR 257 A TYR 262 A TYR 262 A LEU 270 A LEU 270 A LEU 272 A LEU 272 B LYS 6 B LYS 6 B SER 11 B SER 11 B ASN 21 B ASN 21 B PHE 30 B PHE 30 B PHE 62 B PHE 62 B PHE 70 B PHE 70 B GLU 50 B GLU 50 B HIS 51 B HIS 51 B LYS 6 B LYS 6 B SER 11 B SER 11 B ASN 21 B ASN 21 B PHE 30 B PHE 30 B PHE 62 B PHE 62 B PHE 70 B PHE 70 B SER 55 B SER 55 B PHE 56 B PHE 56 B GLU 44 B GLU 44 B ARG 45 B ARG 45 B GLU 36 B GLU 36 B LYS 41 B LYS 41 B TYR 78 B TYR 78 B ASN 83 B ASN 83 B LYS 91 B LYS 91 B LYS 94 B LYS 94 BINDING SITE FOR RESIDUE GOL A1276 Software 8 BINDING SITE FOR RESIDUE GOL A1277 Software 7 A TYR 7 A TYR 7 8 1_555 A GLU 9 A GLU 9 8 1_555 A GLU 63 A GLU 63 8 1_555 A GOL 1277 E GOL 8 1_555 A HOH 2002 F HOH 8 1_555 A HOH 2011 F HOH 8 1_555 A HOH 2015 F HOH 8 1_555 A HOH 2053 F HOH 8 1_555 A GLN 97 A GLN 97 7 1_555 A SER 99 A SER 99 7 1_555 A TYR 159 A TYR 159 7 1_555 A GOL 1276 D GOL 7 1_555 A HOH 2002 F HOH 7 1_555 A HOH 2055 F HOH 7 1_555 C TYR 6 C TYR 6 7 1_555 4 P 1 21 1